Teladoc Health, Inc.
TDOC
$8.93
-$0.22-2.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 640.49M | 640.51M | 642.44M | 646.13M | 660.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 640.49M | 640.51M | 642.44M | 646.13M | 660.53M |
| Cost of Revenue | 188.93M | 179.75M | 188.06M | 194.54M | 193.42M |
| Gross Profit | 451.56M | 460.76M | 454.39M | 451.59M | 467.10M |
| SG&A Expenses | 327.45M | 339.17M | 330.26M | 349.39M | 309.56M |
| Depreciation & Amortization | 89.52M | 89.57M | 96.57M | 97.89M | 97.52M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 682.65M | 680.87M | 691.64M | 723.21M | 690.45M |
| Operating Income | -42.16M | -40.36M | -49.19M | -77.08M | -29.92M |
| Income Before Tax | -48.17M | -32.50M | -833.79M | -79.20M | -25.38M |
| Income Tax Expenses | 238.00K | 780.00K | 3.88M | 2.69M | 3.52M |
| Earnings from Continuing Operations | -48.41M | -33.28M | -837.67M | -81.89M | -28.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.41M | -33.28M | -837.67M | -81.89M | -28.89M |
| EBIT | -42.16M | -40.36M | -49.19M | -77.08M | -29.92M |
| EBITDA | 11.78M | 13.39M | 16.61M | -10.06M | 43.64M |
| EPS Basic | -0.28 | -0.19 | -4.92 | -0.49 | -0.17 |
| Normalized Basic EPS | -0.15 | -0.10 | -0.15 | -0.26 | -0.07 |
| EPS Diluted | -0.28 | -0.19 | -4.92 | -0.49 | -0.17 |
| Normalized Diluted EPS | -0.15 | -0.10 | -0.15 | -0.26 | -0.07 |
| Average Basic Shares Outstanding | 172.77M | 171.50M | 170.23M | 167.73M | 166.06M |
| Average Diluted Shares Outstanding | 172.77M | 171.50M | 170.23M | 167.73M | 166.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
